Dose Escalation Study of Clofarabine in Patients With Relapsed or Refractory Low Grade or Intermediate-Grade B-Cell Lymphoma
Clinical trial NCT00338494 · COMPLETED
Trial details
- NCT number
- NCT00338494
- Sponsor
- Yale University
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-10-01
- Primary completion
- 2010-03-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.